RLFTY — MindMaze Therapeutics Holding SA

OTC · Health Care · Pharmaceuticals · CIK 1854078 · Switzerland
Last close
$0.42
Market Cap
$66.59M
52W High
$2.40
52W Low
$0.27
ADV30
233
Next earnings
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
No quarterly fundamentals indexed for this ticker.

Yahoo Snapshot (yfinance, live)

Total Revenue
$642,000
EBITDA
$-9,143,000
Free Cash Flow
Enterprise Value
Total Cash
Total Debt
Shares Out
157,602,044
Trailing EPS
$-0.59
Book Value
$0.31
ROE
-51.6%
ROA
-25.5%
Div Yield

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 642,000 -10,515,000 -9,906,000 51,530,000 13,189,000 -7,208,000
Dec 2024 0 -2,000 -1,000 93,000 7,000 -3,000

Peers — same industry

TickerNameMarket CapLastDaily %
HYFT MindWalk Holdings Corp. $66.80M $1.43
CING Cingulate Inc. $66.13M $4.91
PMVP PMV Pharmaceuticals, Inc. $66.13M $1.24
EDSA Edesa Biotech, Inc. $67.53M $7.01
MNOV MEDICINOVA INC $68.42M $1.39

News headlines (Yahoo Finance, 1h cache)

MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy
2026-07-09 05:35 · Yahoo
MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe
2026-07-01 05:22 · Yahoo
MindMaze Therapeutics Announces Results of Annual General Meeting
2026-06-25 20:32 · Yahoo
MindMaze Therapeutics Publishes Invitation to the 2026 Annual General Meeting
2026-06-03 05:00 · Yahoo
MindMaze Therapeutics Announces Non-Core Asset Sale and Organizational Simplification
2026-06-02 05:05 · Yahoo
MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
2026-05-26 05:50 · Yahoo
MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S.
2026-05-12 05:25 · Yahoo
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
2026-03-19 06:35 · Yahoo
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
2026-03-12 06:30 · Yahoo
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation
2026-03-03 07:45 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.